Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GN.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FW.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
FW.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.1.2.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
FY.1.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.403NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.1.403NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.636NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.636NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.126NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.126NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BQ.1.1.47NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BQ.1.1.47NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XDQ.3NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XDQ.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JD.1.1.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
JD.1.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.576NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.576NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.325NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.325NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.22NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.22NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.521NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.521NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.378NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.378NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.206NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.206NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.28NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.28NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.77NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
B.1.1.77NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
JN.1.2.1NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
JN.1.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.13.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
HK.13.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HV.1.9NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
HV.1.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3.16NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
XBB.2.3.16NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CN.2NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
CN.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.17NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BA.2.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BG.4NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BG.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.9NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
BF.9NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.4.1.9NYoung-NCTCAGTCCAAGATGGTATTTCT2240.912858328604F-21953.9Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used